Sander Bollen
Leiden University
3 Papers
Sander Bollen is an academic researcher from Leiden University. The author has contributed to research in topics: Cas9 & CRISPR interference. The author has an hindex of 2, co-authored 3 publications. Previous affiliations of Sander Bollen include Max Delbrück Center for Molecular Medicine.
Chat about Author
Papers
CRISPR Immunity Relies on the Consecutive Binding and Degradation of Negatively Supercoiled Invader DNA by Cascade and Cas3
Edze R. Westra,Paul B. G. van Erp,Tim Künne,Shi Pey Wong,Raymond H.J. Staals,Christel L.C. Seegers,Sander Bollen,Matthijs M. Jore,Ekaterina Semenova,Konstantin Severinov,Konstantin Severinov,Willem M. de Vos,Willem M. de Vos,Remus T. Dame,Renko de Vries,Stan J. J. Brouns,John van der Oost +16 more
TL;DR: It is shown that Cascade efficiently locates target sequences in negatively supercoiled DNA, but only if these are flanked by a protospacer-adjacent motif (PAM), which exclusively involves the crRNA-complementary DNA strand.
558
CAFE: an R package for the detection of gross chromosomal abnormalities from gene expression microarray data
TL;DR: CAFE is implemented as an R package that analyzes Affymetrix *.CEL files and comes with flexible plotting functions, easing visualization of chromosomal abnormalities.
Multigene panel sequencing of established and candidate melanoma susceptibility genes in a large cohort of Dutch non-CDKN2A/CDK4 melanoma families.
Thomas P. Potjer,Sander Bollen,Anneliese Grimbergen,Remco van Doorn,Nelleke A. Gruis,Christi J. van Asperen,Frederik J. Hes,Nienke van der Stoep +7 more
TL;DR: It is concluded that multigene panel testing for familial melanoma is appropriate considering the additional 4% diagnostic yield in non‐CDKN2A/CDK4 families, and shows that BAP1 and MITF are important genes to be included in such a diagnostic test.